Cargando…
“The pill” suppresses adolescent bone growth, no matter the estrogen dose
Autores principales: | Brajic, Tatjana S., Goshtasebi, Azita, Goldberg, Tamara B.L., Berenson, Abbey B., Prior, Jerilynn C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687508/ https://www.ncbi.nlm.nih.gov/pubmed/34930769 http://dx.doi.org/10.1503/cmaj.80396 |
Ejemplares similares
-
Adolescent use of combined hormonal contraception and peak bone mineral density accrual: A meta‐analysis of international prospective controlled studies
por: Goshtasebi, Azita, et al.
Publicado: (2019) -
MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020) -
A one-year observational cohort study of menstrual cramps and ovulation in healthy, normally ovulating women
por: Bann, Sewon, et al.
Publicado: (2022) -
MON-LB042 Health-Related Quality of Life in Women with Polycystic Ovary Syndrome/Anovulatory Androgen Excess versus Local Population-Based Control Women (from the British Columbia Canadian Multicentre Osteoporosis Study [BC CaMos])
por: Liang, Bernice, et al.
Publicado: (2019) -
SUN-537 Progesterone Therapy and Serum Sclerostin Levels in Healthy Menopausal Women: A 3-month Randomized, Placebo Controlled Clinical Trial
por: Yang, Yuebo, et al.
Publicado: (2019)